Centre clarifies on 3rd wave possibility after Omicron detection

03-12-2021 Fri 15:51 IST | IANS | Health
Centre clarifies on 3rd wave possibility after Omicron detection

New Delhi, Dec 3:  Omicron cases are increasingly being reported from countries outside of South Africa. India has also reported two cases of Omicron Covid variant and is likely to spread to more countries.

"Given the fast pace of vaccination in India and high exposure to Delta variant as evidenced by high seropositivity, the severity of the disease is anticipated to be low. However, scientific evidence is still evolving," said the Health Ministry on Friday. It added further that the scale and magnitude of rise in cases and most importantly the severity of disease that will be caused is still not clear.

On the question of existing vaccine efficacy against this variant, the health ministry has said that there is no evidence to suggest that existing vaccines do not work on Omicron, some of the mutations reported on Spike gene may decrease the efficacy of existing vaccines. However, vaccine protection is also by antibodies as well as by cellular immunity, which is expected to be relatively better preserved.

"Hence vaccines are expected to still offer protection against severe disease, and vaccination with the available vaccines is crucial. If eligible, but not vaccinated, one should get vaccinated," it added.

The response measures for all variants of concern, including Omicron, is the same as that for SARs CoV2. The ministry has said that the precautions and steps to be taken remain the same as before. "It is essential to mask yourself properly, take both doses of vaccines (if not yet vaccinated), maintain social distancing and maintain good ventilation to the maximum possible", said the ministry in a statement.

The government is monitoring the situation closely and is issuing suitable guidelines, said the ministry, adding that the scientific and medical community is geared up for developing and deploying diagnostics, carrying out genomic surveillance, generating evidence about viral and epidemiologic characteristics, and development of therapeutics.


More News
Hindi version of 'Pushpa' director's 'Rangasthalam' set for Feb release
1 hour ago
Andhra CM roots for 'One district, One airport' concept
1 hour ago
Andhra's active Covid cases surge to over 53K
1 hour ago
Ganguly wanted to issue show cause notice to Kohli after his press conference outburst: Report
2 hours ago
New film studio to be built in space by 2024
2 hours ago
Australian Open: Sania Mirza-Rajeev Ram advance to mixed doubles second round
3 hours ago
Dolo pill breaks sales record in pandemic as manufacturer makes a fortune
3 hours ago
PM to unveil 216-ft 'Statue of Equality' in Hyd on Feb 5
3 hours ago
Covid booster dose provides good antibody protection against Omicron: Lancet
3 hours ago
A murder mystery unearthing the dark world of Bollywood
3 hours ago
No place for discrimination in India, says PM Modi
5 hours ago
Rs 7,411 cr deposited in Telangana farmers' bank accounts
5 hours ago
Lakshmi Manchu urges Telangana govt to institutionalise digital education
5 hours ago
Sharma, Pant and Ashwin included in ICC Men's Test Team of the Year
5 hours ago
IND vs SA, 2nd ODI: With series on the line, India hope to put up better batting show
6 hours ago
Balakrishna's 'Akhanda' completes 50 days in theatres successfully
7 hours ago
Meera Jasmine opens Instagram account, posts still from comeback movie 'Makal'
7 hours ago
Pay revision: Andhra teachers take to streets
8 hours ago
Microsoft announces general availability of Surface Pro 8 in India
9 hours ago
UK PM announces expiration of strict Plan B Covid restrictions
9 hours ago